Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Edscharp who wrote (16894)	6/3/2004 5:41:04 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Ed, I didn't know Xoma was trying to cure acne. As a matter of fact I don't know of any biotech trying to cure acne. But then again only a fool like yourself would think a cure is around the corner. Too bad there isn't a sour grapes website for fools like yourself. Last time I checked Raptiva was Genentech's molecule and carried Xoma. But hey, you lost your shirt in Xoma investing so why bother with the facts. Too bad, your foolish investing wasn't fiction. As always best regards.

To: Edscharp who wrote (16894)	6/3/2004 6:39:28 PM
From: Bluegreen	Respond to of 17367

Ed, your middle name isn't "ain't so" is it? I thought the Psoriais board was interesting. Only a fool like yourself would make grandoise claims on something someone found and stated as just interesting and never seen before. Ed, your lost money in Xoma isn't coming back. Face it. Get over it. Now, a very good way to bash Xoma is to bring up the possible Micrologix competition. Another way is to keep bringing up the fact that Raptiva might not get European approval. BTW, Chiron doesn't align itself with chump Biotechs.